Publication
Quality of Life and characterization of patients with atopic dermatitis in Portugal - QUADEP study
| dc.contributor.author | Carvalho, D | |
| dc.contributor.author | Aguiar, P | |
| dc.contributor.author | Mendes-Bastos, P | |
| dc.contributor.author | Palma-Carlos, A | |
| dc.contributor.author | Freitas, J | |
| dc.contributor.author | Ferrinho, P | |
| dc.date.accessioned | 2019-09-22T21:52:18Z | |
| dc.date.available | 2019-09-22T21:52:18Z | |
| dc.date.issued | 2019-09-18 | |
| dc.description.abstract | OBJECTIVES: To investigate the quality of life (QoL) and to characterize patients with atopic dermatitis (AD) in Portugal. METHODS: This was a cross-sectional study, including patients with AD and other eczemas. Skindex-29, Skindex-teen and Childhood Atopic Dermatitis Impact Scale (CADIS) were the instruments used to assess QoL in adults, teenagers, and children respectively. Complementarily, the SF-12 was used and disease severity was evaluated through Patient-Oriented SCORAD (PO-SCORAD). Odds Ratio (OR) were performed to measure associations with QoL. SPSS statistics 95% confidence intervals and values of p<0.05 were considered statistically significant. RESULTS: 162 participants were included, aging 0.5-74 years. We found that 37.3% of AD patients consider their disease as disabling and more than half of AD patients feel stigmatized by society. The mean Skindex score for AD was 39.68, and 44% patients presented a severe QoL impact. "Symptoms" was the most affected category in adults. Moderate to severe AD patients were 87% of the sample. Regarding the factors that most influenced worse QoL in AD, with increasing age, the Skindex score is likely to increase (OR: 1.03 [95%CI 1.00-1.06]). "Consider having disability" was also associated, OR: 6.72 (95%CI 2.56-17.63). With increasing affected body area and edema, the QoL worsens (OR: 1.07 [95%CI 1.03-1.11] and OR: 2.04 [95%CI 1.23-3.40], respectively). CONCLUSIONS: This is the first study with QoL data about AD patients in Portugal, revealing an expected negative impact. More awareness-raising activities are needed to increase literacy, decrease the stigma, and consequently to address some impacted factors in AD patients' QoL. | pt_PT |
| dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
| dc.identifier.citation | J Investig Allergol Clin Immunol. 2019 Sep 18:0. | pt_PT |
| dc.identifier.doi | 10.18176/jiaci.0443 | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.26/29769 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | Dermatite Atópica | pt_PT |
| dc.subject | Qualidade de Vida | pt_PT |
| dc.subject | Dermatitis, Atopic | pt_PT |
| dc.subject | Quality of Life | pt_PT |
| dc.title | Quality of Life and characterization of patients with atopic dermatitis in Portugal - QUADEP study | pt_PT |
| dc.type | journal article | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 6 | pt_PT |
| oaire.citation.startPage | 0 | pt_PT |
| oaire.citation.volume | 30 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Quality of Life and characterization of patients with atopic dermatitis in Portugal.pdf
- Size:
- 1.44 MB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.85 KB
- Format:
- Item-specific license agreed upon to submission
- Description:
